New challenges in drug combination and strategies
New challenges in drug combination and strategies
Editor's choice for October 2015
Targeting N-RAS mutated tumours
HVEM expression in melanoma metastasis: prognosis correlation
Vemurafenib in patients with BRAF600 mutation–positive metastatic melanoma
Obesity and tobacco use increasing global cancer burden
Research reproducibility and scientific ecosystems
Reduced fractionation radiotherapy feasible for localised prostate cancer
Geonomic testing may help predict metastatic risk after prostatectomy and salvage radiotherapy
Deintensified chemoradiation for HPV-associated oropharyngeal cancer
Accelerated partial breast irradiation valid alternative to whole breast irradiation in early breast cancer
Image-guided IMRT reduces bowel effects in cervical cancer patients